Aims & scope

Launched in May 2022, Vaccine Insights is a new peer-reviewed, open-access journal with a translational focus. 

The COVID-19 pandemic has put vaccine R&D and production under the spotlight like never before, bringing a raft of fresh opportunities and challenges – from new and emerging vaccine platforms to the ever-evolving regulatory landscape. 

Vaccine Insights brings together leading experts from pharma, biotech, academia, and other key stakeholders to address critical issues and put the latest developments into context – sifting through the deluge of data to reveal valuable insights into where the field is heading.

Guided by an expert advisory board, the journal covers the most important advances in vaccine development and manufacturing across all disease areas, for both prophylactic and therapeutic vaccines. Topics include:

  • Preclinical and translational research
  • Emerging vaccine platforms
  • Clinical development
  • Regulatory affairs
  • Formulation and administration
  • Process development and manufacture
  • CMC and analytics
  • Raw and starting materials and supply chain
  • Enabling tools and technology
  • Policy and access

Vaccine Insights helps readers stay up to date with this rapidly evolving field via accessible and timely reviews, commentary and analysis, original research articles, roundtable discussions, webinars, and podcasts.